Oragenics Inc. Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: Jul 22, 2024 · CIK: 1174940
Sentiment: neutral
Topics: 8-K, filing, financial-update
TL;DR
Oragenics filed an 8-K today, likely with financial updates. Keep an eye out for details.
AI Summary
On July 22, 2024, Oragenics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and business operations. Specific details regarding the nature of these events or exhibits are not provided in the excerpt.
Why It Matters
This filing signals that Oragenics, Inc. has made a significant disclosure to the SEC, which could contain important information for investors regarding the company's financial health or strategic developments.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report, which typically contains routine disclosures and does not inherently signal high risk without further context.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- July 22, 2024 (date) — Date of Report
- 1990 Main Street Suite 750 Sarasota, FL 34236 (address) — Principal executive offices
- 813 - 286-7900 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by Oragenics, Inc. in this 8-K filing?
The provided excerpt does not specify the details of the "Other Events" reported in the 8-K filing.
What "Financial Statements and Exhibits" are included with this 8-K filing?
The excerpt indicates that "Financial Statements and Exhibits" are part of the filing, but does not list their specific contents.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 22, 2024.
What is Oragenics, Inc.'s principal executive office address?
Oragenics, Inc.'s principal executive office is located at 1990 Main Street Suite 750 Sarasota, FL 34236.
What is the Commission File Number for Oragenics, Inc.?
The Commission File Number for Oragenics, Inc. is 001-32188.
Filing Stats: 458 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-07-22 16:05:34
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-24-028687.txt ( ) — 207KB
- ogen-20240722.xsd (EX-101.SCH) — 3KB
- ogen-20240722_lab.xml (EX-101.LAB) — 33KB
- ogen-20240722_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 22nd day of July, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer